Nocera, Inc. (NCRA) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated January 12, 2026, reports the results of Nocera, Inc.'s 2025 Annual Meeting of Stockholders held virtually on that date. The Company is incorporated in Nevada and trades on The Nasdaq Stock Market LLC under the symbol NCRA. As of the record date (October 29, 2025), there were 14,373,597 shares of common stock outstanding. Approximately 87.33% of outstanding shares were represented at the meeting, establishing a quorum.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt levels, or liquidity ratios. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Stockholders approved six key proposals at the Annual Meeting:
- Election of Directors: Five nominees (Andy Chin-An Jin, Sean Fislon, Hui-Ying Zhuang, Yiwen Zhang, and Song-Yuan Teng) were elected unanimously with 12,551,955 votes for and only 100 votes withheld per nominee.
- Ratification of Auditors: Enrome LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Series B Convertible Preferred Stock: Approved the potential issuance of common stock upon conversion of Series B Convertible Non-Voting Preferred Stock in excess of 19.99% of outstanding shares, potentially below the Nasdaq Minimum Price.
- Reverse Stock Split: Authorized the Board to effect a reverse stock split at any time within the next year at a ratio between 1:5 and 1:100.
- Authorized Share Increase: Approved increasing authorized common stock from 200,000,000 to 2,000,000,000 shares.
- Convertible Note Issuance: Approved the potential issuance of common stock upon conversion of senior secured convertible notes (dated October 31, 2025) in excess of 19.99% of outstanding shares, potentially below the Nasdaq Minimum Price.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors beyond the implications of the approved proposals. The approval of the reverse stock split and the issuance of convertible securities below the Nasdaq Minimum Price suggests the Company is taking measures to maintain listing compliance and manage capital structure, which may involve significant dilution to existing shareholders.
Investor Verification Checklist
- Verify the specific ratio and effective date of the reverse stock split once determined by the Board.
- Review the terms of the Securities Purchase Agreement dated October 31, 2025, regarding the senior secured convertible notes.
- Monitor the dilution impact resulting from the conversion of Series B Preferred Stock and the new convertible notes.
- Confirm the Company's compliance with Nasdaq listing requirements following the approved capital structure changes.